title: Cardiovascular actions of central neuropeptide W in conscious rats.
abstract: Neuropeptide W (NPW) is a novel hypothalamic peptide that activates the orphan G protein-coupled receptors, GPR7 and GPR8. Two endogenous molecular forms of NPW that consist of 23- and 30-amino acid residues were identified. Intracerebroventricular (i.c.v.) administration of NPW is known to suppress spontaneous-feeding at dark-phase and fasting-induced food intake and to decrease body weight and plasma growth hormone and to increase prolactin and corticosterone; however, little is known about its effect on other physiological functions. We examined the effects of i.c.v. administration of NPW30 (0.3 and 3 nmol) on the mean arterial pressure (MAP), heart rate (HR), and plasma norepinephrine and epinephrine in conscious rats. NPW30 (3 nmol) provoked increases in MAP (85.12+/-3.16 to 106.26+/-2.66 mm Hg) and HR (305.75+/-13.76 to 428.45+/-26.82 beats/min) and plasma norepinephrine (138.1+/-18.1 to 297.2+/-25.9 pg/ml) and epinephrine (194.6+/-21.4 to 274.6+/-22.7 pg/ml). Intravenously administered NPW30 (3 nmol) had no significant effects on MAP and HR. These results indicate that central NPW30 increases sympathetic nervous outflow and affects cardiovascular function.
authors.affiliation: Department of Physiology, Faculty of Medicine, University of Miyazaki 5200 Kihara, Kiyotake-cho, Miyazaki-gun, Miyazaki 889-1692, Japan.
authors.forename: Nanshou
authors.initials: N
authors.lastname: Yu
authors.forename: Chunping
authors.initials: C
authors.lastname: Chu
authors.forename: Takato
authors.initials: T
authors.lastname: Kunitake
authors.forename: Kazuo
authors.initials: K
authors.lastname: Kato
authors.forename: Masamitsu
authors.initials: M
authors.lastname: Nakazato
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kannan
mesh_terms: D000818:Animals; D002320:Cardiovascular Physiological Phenomena / Q000187:drug effects*; D002395:Catecholamines / Q000097:blood; D003243:Consciousness; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D007276:Injections, Intraventricular; D008297:Male; D009479:Neuropeptides / Q000008:administration & dosage / Q000494:pharmacology*; D009638:Norepinephrine / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
chemical_list: D002395:Catecholamines; D009479:Neuropeptides; C496874:neuropeptide W, rat; D009638:Norepinephrine; D004837:Epinephrine